Each finding is printed with the count for its class. No class has 15 admissible resolved forecasts, so no figure across a
class is printed here.
FF-007 · US Food and Drug Administration (FDA) · registered 84% on 2026-09-26 · adjudicated 2026-11-12
FF-007: occurred on time. FDA action by goal date: 2 resolved, 33 unresolved, 0 expired (36 registered); not scored: 1 ambiguous. One forecast is one instance, not a rate.
FF-010 · US Food and Drug Administration (FDA) · registered 45% on 2026-09-26 · adjudicated 2026-11-21
FF-010: occurred on time. FDA action by goal date: 2 resolved, 33 unresolved, 0 expired (36 registered); not scored: 1 ambiguous. One forecast is one instance, not a rate.
FF-016 · National Institute for Health and Care Excellence (NICE) · registered 45% on 2026-09-26 · adjudicated 2026-11-04
FF-016: did not occur. NICE guidance by scheduled date: 4 resolved, 24 unresolved, 0 expired (28 registered). One forecast is one instance, not a rate.
FF-017 · National Institute for Health and Care Excellence (NICE) · registered 50% on 2026-09-26 · adjudicated 2026-11-10
FF-017: did not occur. NICE guidance by scheduled date: 4 resolved, 24 unresolved, 0 expired (28 registered). One forecast is one instance, not a rate.
FF-019 · National Institute for Health and Care Excellence (NICE) · registered 45% on 2026-09-26 · adjudicated 2026-11-18
FF-019: did not occur. NICE guidance by scheduled date: 4 resolved, 24 unresolved, 0 expired (28 registered). One forecast is one instance, not a rate.
FF-022 · National Institute for Health and Care Excellence (NICE) · registered 50% on 2026-09-26 · adjudicated 2026-11-19
FF-022: did not occur. NICE guidance by scheduled date: 4 resolved, 24 unresolved, 0 expired (28 registered). One forecast is one instance, not a rate.
FF-012 · US Food and Drug Administration (FDA) · adjudicated 2026-11-15
FF-012: ambiguous, handled by the rule. FDA action by goal date: 2 resolved, 33 unresolved, 0 expired (36 registered); not scored: 1 ambiguous.